LANTHEUS HOLDINGS INC (LNTH) Stock Price, Quote, News and Overview
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
LNTH Quote, Performance and Key Statistics
LANTHEUS HOLDINGS INC
NASDAQ:LNTH (1/23/2025, 9:16:25 PM)
After market: 97.63 0 (0%)97.63
+2.24 (+2.35%)
The current stock price of LNTH is 97.63 USD. In the past month the price increased by 9.35%. In the past year, price increased by 84.63%.
LNTH Latest News, Press Releases and Analysis
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
Investors should take note ofLANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock that remains attractively priced.
Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
Enhances Lantheus’ growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for...
LNTH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.51 | 44.53B | ||
| COO | COOPER COS INC/THE | 25.86 | 19.10B | ||
| ALGN | ALIGN TECHNOLOGY INC | 25.2 | 17.53B | ||
| SOLV | SOLVENTUM CORP | 17.69 | 12.72B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.85 | 6.04B | ||
| BLCO | BAUSCH + LOMB CORP | 27.62 | 5.93B | ||
| ICUI | ICU MEDICAL INC | 29.42 | 4.09B | ||
| XRAY | DENTSPLY SIRONA INC | 10.51 | 3.86B | ||
| HAE | HAEMONETICS CORP/MASS | 17.86 | 3.66B | ||
| NEOG | NEOGEN CORP | 29.35 | 2.54B | ||
| UFPT | UFP TECHNOLOGIES INC | 37.45 | 2.01B | ||
| RXST | RXSIGHT INC | N/A | 1.31B |
Related screens
About LNTH
Company Profile
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The company is headquartered in North Billerica, Massachusetts and currently employs 834 full-time employees. The company went IPO on 2015-06-25. The firm classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.
Company Info
LANTHEUS HOLDINGS INC
331 Treble Cove Rd
North Billerica MASSACHUSETTS 01862 US
CEO: Mary Anne Heino
Employees: 834
Company Website: https://www.lantheus.com/
Investor Relations: https://investor.lantheus.com
Phone: 19786718001
LNTH FAQ
What is the price of LNTH?
The current price of LNTH is 97.63 USD.
What is the symbol for LANTHEUS HOLDINGS INC?
The exchange symbol of LANTHEUS HOLDINGS INC is LNTH and it is listed on the Nasdaq exchange.
On which exchange is LNTH listed?
LNTH is listed on the Nasdaq exchange.
Is LNTH a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for LNTH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of LNTH.
Does LNTH pay dividends?
LNTH does not pay a dividend.
When does LNTH report earnings?
LNTH will report earnings on 2025-02-20, after the market close.
What is the Price/Earnings (PE) ratio of LNTH?
The PE ratio for LNTH is 14.07. This is based on the reported non-GAAP earnings per share of 6.94 and the current share price of 97.63 USD.
What is the Short Interest ratio of LNTH?
The outstanding short interest for LNTH is 9.14% of its float.
LNTH Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to LNTH. When comparing the yearly performance of all stocks, LNTH is one of the better performing stocks in the market, outperforming 88.75% of all stocks.
LNTH Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to LNTH. LNTH gets an excellent profitability rating and is at the same time showing great financial health properties.
LNTH Financial Highlights
Over the last trailing twelve months LNTH reported a non-GAAP Earnings per Share(EPS) of 6.94. The EPS increased by 18.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.57% | ||
| ROA | 20.86% | ||
| ROE | 36.25% | ||
| Debt/Equity | 0 |
LNTH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to LNTH. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 10.02% and a revenue growth 18.4% for LNTH